Product Pipeline

Success of a program centers on the number of products that have reached the market with our assistance. The ultimate validation for any technology transfer office is products on the market. Everybody likes to talk about patents filed and licenses negotiated, but that really isn't the end justification for technology transfer. It's completing the cycle of investing in research and having that effort improve people's lives. Emory has been fortunate to have over 65 products reach the market, with several having a significant, positive impact on society. Below see our list of products that have reached the market and promising discovery that we hope will.

Therapeutics

ProductLicenseeIndication

Pre-clinical

Phase IPhase IIPhase IIINDA/BLAMarket
3TC (1. Epivir®)GlaxoSmithKline/ShireHIVmarket
3TC (2. Combivir®)GlaxoSmithKline/ShireHIVmarket
3TC (3. Trizivir®)GlaxoSmithKline/ShireHIVmarket
3TC (4. Epzicom®)GlaxoSmithKline/ShireHIVmarket
3TC (5. Triumeq®)ViiV HealthcareHIVmarket
3TC (6. Dutrebis™)GlaxoSmithKline/ShireHIVmarket
3TC (7. Cimduo / Temixys™)Viatris / CeltrionHIVmarket
3TC (8. Symfi™)ViatrisHIVmarket
3TC (9. Delstrigo™)MerckHIVmarket
3TC (10. Dovato)ViiV HealthcareHIVmarket
3TC (11. Temixys™)ViiV HealthcareHIVmarket
3TC (Epivir-HBV®)GlaxoSmithKline/ShireHBVmarket
FTC (1. Emtriva®)Gilead Sciences, Inc.HIVmarket
FTC (2. Truvada®)Gilead Sciences, Inc.HIVmarket
FTC (3. Atripla®)Gilead Sciences, Inc.HIVmarket
FTC (4. Complera®)Gilead Sciences, Inc.HIVmarket
FTC (5. Stribild™)Gilead Sciences, Inc.HIVmarket
FTC (6. Genvoya®)Gilead Sciences, Inc.HIVmarket
FTC (7. Odefsey®)Gilead Sciences, Inc.HIVmarket
FTC (8. Descovy®)Gilead Sciences, Inc.HIVmarket
FTC (9. Biktarvy®)Gilead Sciences, Inc.HIVmarket
FTC (10. Symtuza®)JanssenHIVmarket
Olumiant® (Baricitinib)Eli Lilly
COVID-19market
Tyzeka™ (telbivudine) *Idenix Pharma. HBVmarket
OBIZUR (rpfVIII)Baxalta US, Inc.Hemophiliamarket
XIPERE™Clearside Biomedical, Inc.Macular Edemamarket
CLS 1001Clearside Biomedical, Inc.Drug DeliveryRegistration
RGX-121RegenXBIOHunter Syndromephase 1
LAGEVRIO™ (molnupiravir)**Merck/RidgebackCOVID-19Registration
Elate Ocular™Cambium MedicalDry Eyephase 2
ALG-000184Aligos TherapeuticsHBVphase 1
DNA/MVA HIV VaccineGeoVax, Inc.HIV/Prophylacticphase 2
E-WE ThrombinAronora, IncIschemic Stroke/ Heart Attackphase 2
GALE-401BiovascularThrombocythemiaphase 2
INB-400Aronora, IncCancerphase 2
Q-122QUE OncologyHot Flashesphase 2
SamuraciclibCarrick TherapeuticsBreast Cancerphase 2
DNA/MVA VaccineGeoVax, Inc.HIV/ Therapeuticphase 1
INB-100GeoVax, Inc.Cancerphase 1
INB-200GeoVax, Inc.Cancerphase 1
Anti-CD40 AntibodyKiniksa PharmaceuticalsTransplant Rejection/ Autoimmunepreclinical
EIDD-1931DRIVEEmerging Diseasepreclinical
Hemodialysis SystemBaxter BioscienceKidney Failure/ Dialysispreclinical
NMDAR-R2B BlockerNeurOp Corporation Ischemia/ Painpreclinical
r13 (7,8-DHF prodrug)Shanghai Braegen Alzheimer’s/ Painpreclinical

Diagnostic/Device Products

Requiring 510K Regulatory Processes

ProductLicenseeIndicationPrototypeRegistration
Trial(s)		510(k)/PMA
Application		Market
AlignRT® PlusVisionRT, Ltd.Radiation Therapymarket
AnemoCheck™SanguinaAnemiamarket
Arctic Front™Biosense WebsterAtrial Fibrillationmarket
Arctic Front Advanced™Biosense WebsterAtrial Fibrillationmarket
ClearGlide®Sorin Group USAVein Harvestingmarket
Emory Cardiac Toolbox™Syntermed, Inc.Cardiac Imagingmarket
ExSPECT II™*Syntermed/PhilipsCardiac Imagingmarket
Fragile X Diagnostic Test *Quest and othersFragile X Syndromemarket
NeoControl®*Neotonus, Inc.Incontinencemarket
NeuroStar® TMS TherapyNeuronetics, LLCDepressionmarket
Ocelot™TendoNovaTendinopathymarket
PETtools™*Syntermed, Inc.Cardiac Imagingmarket
PVAC™Biosense WebsterAtrial Fibrillationmarket
QuantEM™GE Medical SystemsRenal Imagingmarket
ReconTools™ (ERTb™)*Syntermed, Inc.Cardiac Imagingmarket
SurgicalPreview™AngioCloudVascular Imagingmarket
Sync tools™Syntermed, Inc.Cardiac Imagingmarket
VelocityAI™Varian Medical SystemsOncology Imagingmarket
ACS SystemThoratec CorporationVascular SurgeryRegistration
Beta-Cath™Best Vascular, Inc.Restenosismarket
C-Heart®CovanosCornary Softwaremarket

Diagnostic/Device Products

Requiring IND/IDE/NDA Regulatory Processes

ProductLicenseeIndicationPreclinicalPhase IPhase IIPhase IIINDAMarket
Axumin®Nihon-Medi-PhysicsTumor Imagingphase 1
Imaging AgentMicrobial MedicalBacterial Infectionphase 1

Consumer and Other Products

ProductLicenseeIndicationIn DevelopmentMarket
ACU-SIBRCentripitalHospital Roundsmarket
Alzheimer’s DiagnosticNeurotrackAlzheimer’s Diagnosticmarket
AnemoCheck™ HomeSanguinaAlzheimer’s Diagnosticmarket
The Beast™*Avid CapitalOR Table Attachmentmarket
BrijjitEMRGEWound Closure & Healingmarket
Diabetes TestingDiasystDiabetesmarket
Duralast (antimicrob.)*Duraban InternationalAntimicrobial Coatingmarket
Genetic TestingEGL Genetics DiagnosticsGenetic Testingmarket
Goldshield® products*AuProvise, S.A.Antimicrobial Shieldmarket
Handy Eye Chart™*Apple BoxVision Testingmarket
Jacobson Micro ScissorsICT/Scanlan Int.Vascular Surgerymarket
The NozeBot™Dr Noze BestNasal Congestionmarket
Ostomy Odor Elimination SystemBe Free TechnologiesOstomymarket
Prokopack*MultipleBug Catchermarket
RealConsent™MultipleSexual Assault Trainingmarket
Sanctum GuardKeystrikeCybersecuritymarket
SERQET™*LAAMScienceAntimicrobial Coatingmarket
Sucrets® DEFENSE *GSH Biomedical Ltd.Immune System Boostmarket
Titanium ForcepsICT/Scanlan Int.Surgerymarket
VRET SolutionsVirtually BetterVirtual Reality Therapymarket

* No longer on the market
** LAGEVRIO™ (molnupiravir) is on the market under Emergency Use Authorization in the U.S. but has been approved by foreign regulatory agencies.

Note: A non-exhaustive list of technologies/products that have not received market approval.

© Emory University, Office of Technology Transfer